Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Joseph Elan Grossman

机构：Beth Israel Deaconess Medical Center, Harvard University, Agenus (United States) · ORCID：0000-0002-2130-2783

发表论文 159 篇 · 总被引 1043 次 · h-index 13

代表论文

  • Extended Follow-up of Botensilimab plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer without Active Liver Metastases (2026 · Clinical Cancer Research)
  • Supplementary Table S8 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)
  • Supplementary Figure S11 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)
  • Supplementary Table S7 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)
  • Supplementary Table S1 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)
  • Supplementary Figure S5 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)